Kaitlyn K.H. Goey

Maintenance treatment with capecitabine and bevacizumab versus observation in metastatic colorectal cancer: updated results and molecular subgroup analyses of the phase 3 CAIRO3 study

Kaitlyn K.H. Goey, Sjoerd G. Elias, Harm van Tinteren et al. · Annals of Oncology · 2017 · 78 citations · Full text

Gastrointestinal Oncology, Medicine, Pharmacology +9

Prognostic value of primary tumour resection in synchronous metastatic colorectal cancer: Individual patient data analysis of first-line randomised trials from the ARCAD database

Karlijn L. van Rooijen, Qian Shi, Kaitlyn K.H. Goey et al. · European Journal of Cancer · 2018 · 74 citations

Surgical Oncology, Arcad Database, Colorectal Surgery +10

Consensus statement on essential patient characteristics in systemic treatment trials for metastatic colorectal cancer: Supported by the ARCAD Group

Kaitlyn K.H. Goey, Halfdan Sørbye, Bengt Glimelius et al. · European Journal of Cancer · 2018 · 33 citations

Surgical Oncology, Gastrointestinal Oncology, Medicine +9

BRAFV600E in colorectal cancer reduces sensitivity to oxidative stress and promotes site-specific metastasis by stimulating glutathione synthesis

Jamila Laoukili, Susanne van Schelven, Emre Küçükköse et al. · Cell Reports · 2022 · 22 citations · Full text

Clinicopathological factors influencing outcome in metastatic colorectal cancer patients treated with fluoropyrimidine and bevacizumab maintenance treatment vs observation: an individual patient data meta-analysis of two phase 3 trials

Kaitlyn K.H. Goey, Sjoerd G. Elias, Axel Hinke et al. · British Journal of Cancer · 2017 · 11 citations · Full text